Heterocyclic Ester Synthesis via Carbonylation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current processes for preparing heterocyclic ester derivatives, particularly for protein tyrosine kinase inhibitors like c-fms kinase inhibitors, are not suitable for large-scale manufacture due to high temperatures, expensive reagents, and inefficient regioselectivity.
Innovation Solution
A process involving reacting a compound of formula (VIII) with carbon monoxide in the presence of a tertiary organic base and a coupling system in an alcohol solvent at temperatures between 60° C to 120° C to yield the corresponding compound of formula (I), which is a heterocyclic ester derivative suitable for large-scale production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If bromine-magnesium exchange or deprotonation with alkyllithium is used to introduce the carboxylate group, then the heterocyclic ester derivative can be prepared, but the process requires low temperatures and expensive reagents which are not suitable for large scale process manufacture
Solution Approach 1:
The invention changes the reaction parameters from low temperature to elevated temperature (60-120°C), and from expensive reagents (alkyllithium, bromine-magnesium exchange) to inexpensive reagents (sodium hydroxide, carbon monoxide). This parameter change maintains regioselectivity while enabling large-scale manufacture.
Solution Approach 2:
The invention replaces expensive reagents with inexpensive, readily available materials. Sodium hydroxide and carbon monoxide are used instead of costly alkyllithium or halogen-magnesium exchange reagents, making the process economically viable for large-scale production.
2Quantity of substance
If carbonylation conditions with inorganic base and temperature greater than 100°C are used, then the carboxylate group can be introduced, but the process is not preferred for large scale manufacture
Solution Approach 1:
The invention optimizes the temperature parameter to a specific range (60-120°C) that is high enough to enable carbonylation but controlled enough for safe large-scale operation. The base is specified as sodium hydroxide at controlled concentrations, balancing reactivity with manufacturability.
3Manufacturing precision
If standard procedures for amide bond formation or activated esters are used, then the heterocyclic acid can be coupled, but the process requires expensive reagents and complex conditions
Solution Approach 1:
The invention extracts the carboxylate group introduction step from the traditional amide bond formation sequence. By directly introducing the carboxylate group onto the heterocyclic ring, the need for separate protection, activation, and coupling steps is eliminated, simplifying the overall process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process enables the efficient production of heterocyclic ester derivatives as intermediates for protein tyrosine kinase inhibitors, specifically c-fms kinase inhibitors, with improved regioselectivity and cost-effectiveness for large-scale manufacture.
Implementation Method 1
reacting a compound of formula (VIII) with carbon monoxide in the presence of a tertiary organic base and a coupling system in an alcohol solvent at temperatures between 60° C to 120° C to yield the corresponding compound of formula (I), which is a heterocyclic ester derivative
Data Source
AI summary
The present invention is directed to a process for the preparation of heterocyclic ester derivatives of formula Iwherein A1, SEM, and W1 are as defined herein. Such compounds are useful as intermediates in the synthesis of derivatives useful as protein tyrosine kinase inhibitors, more particularly inhibitors of c-fms kinase.